首页>
外国专利>
THERAPEUTIC AGENT FOR OVARIAN CLEAR CELL ADENOCARCINOMA TARGETED FOR N-myc DOWNSTREAM REGULATED GENE 1 PROTEIN
THERAPEUTIC AGENT FOR OVARIAN CLEAR CELL ADENOCARCINOMA TARGETED FOR N-myc DOWNSTREAM REGULATED GENE 1 PROTEIN
展开▼
机译:针对N-myc下游调节基因1蛋白的卵巢透明细胞腺癌的治疗剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
PROBLEM TO BE SOLVED: To provide a new therapeutic agent for ovarian clear cell adenocarcinoma targeted for a protein specifically developed in this disease.;SOLUTION: A therapeutic agent and/or a preventive agent of clear cell adenocarcinoma includes a substance which can inhibit the function of or suppress the development of, the N-myc downstream regulated gene 1 protein in a clear cell adenocarcinoma cell. A drug that reduces the anticancer drug resistance of clear cell adenocarcinoma contains a substance which can inhibit the function of or suppress the development of, the N-myc downstream regulated gene 1 protein in a clear cell adenocarcinoma cell.;COPYRIGHT: (C)2013,JPO&INPIT
展开▼